The company’s official press release [1] provides more details on neutralizing titers against BA.4/BA.5 which are the emerging Omicron variants today vs. BA.1 w

The company’s official press release [1] provides more details on neutralizing titers against BA.4/BA.5 which are the emerging Omicron variants today vs. BA.1 which was the original Omicron variant. The result is noteworthy in light of recent research [2]. [1]: https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-Bivalent-Booster-mRNA-1273.214-Demonstrates-Potent-Neutralizing-Antibody-Response-Against-Omicron-Subvariants-BA.4-And-BA.5/default.aspx https://investors.modernatx.com/news/news-details/2022/Moder... [2]: https://www.nejm.org/doi/full/10.1056/NEJMc2206576 https://www.nejm.org/doi/full/10.1056/NEJMc2206576